Sigma-1 receptor agonists as potential protective therapies in multiple sclerosis. Lisak RP, Nedelkoska L, Benjamins JA. J Neuroimmunol 2020;342:577188.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lisak RP, Nedelkoska L, Benjamins JA. Sigma-1 receptor agonists as potential protective therapies in multiple sclerosis. J Neuroimmunol 2020;342:577188.
PMID: 32179326